Proparacaine HCl Ophthalmic Solution Rx
Generic Name and Formulations:
Proparacaine HCl 0.5%; contains benzalkonium chloride.
Various generic manufacturers
Indications for Proparacaine HCl Ophthalmic Solution:
For procedures in which a topical ophthalmic anesthetic is indicated: corneal anesthesia of short duration (eg, tonometry, gonioscopy, removal of corneal foreign bodies), and for short corneal and conjunctival procedures.
Adults and Children:
Removal of foreign bodies and sutures, and for tonometry: 1–2 drops in each eye before operating. Short corneal and conjunctival procedures: 1 drop in each eye every 5–10 minutes for 5–7 doses.
Not for injection into eye. Permanent corneal opacification with accompanying visual loss with prolonged use. Pregnancy (Cat.C). Nursing mothers.
Rapidly-acting topical anesthetic.
Local effects (eg, stinging, burning, conjunctival redness); rare: severe, immediate-type hyperallergic corneal reaction.
Formerly known under the brand name Ophthetic.
Endocrinology Advisor Articles
- Single Blood Sample Highly Predictive for Subsequent Diabetes Diagnosis
- Adjunctive Metformin for Insulin Resistance in T1D: A Clinical Perspective
- Effect of Fructose, Allulose on Postprandial Glucose Regulation in Type 2 Diabetes
- Sex Hormone Levels May Affect Postmenopausal Heart Disease Risk
- Menopausal Hormone Therapy Slows Cognitive Decline in Postmenopausal Women
- Diabetes Treatments
- Metformin May Decrease Colorectal Cancer Risk Among Males With Diabetes
- SGLT2 Inhibitor, GLP-1 Receptor Agonist Combination Treatment for Type 2 Diabetes: Expert Insights
- Semaglutide May Induce Weight Loss in Type 2 Diabetes Despite BMI
- FDA Clears Omnipod DASH System for Diabetes Management
- Effect of Infant Feeding Practices and Gut Microbiota on Overweight in First Year
- Empagliflozin, Linagliptin Combination Therapy vs Linagliptin Monotherapy for Type 2 Diabetes
- Cleared Blood Glucose Monitor Systems Not Always Accurate
- CDC: Obesity Prevalence Higher in Non-Metropolitan Counties
- Vascular Mortality Declining in Adults With Diabetes in the United States